| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bausch Health Companies Inc. (BHC) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. BHC is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 73.26M | $342.10M | - | |
| CEO | 2.92M | $13.64M | - | |
| VP | 637.5K | $2.98M | - | |
| Dir | 360.1K | $1.68M | - | |
| Dir | 282.2K | $1.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2017 | De Schutter Richard U | Director | Buy | 20,000 | $13.90 | $278,000.00 | +39.5% | |
| Mar 15, 2017 | De Schutter Richard U | Director | Buy | 10,000 | $10.80 | $108,000.00 | +65.8% | |
| Mar 14, 2017 | Valueact Holdings, L.P.73 | Director, See Remarks | Buy | 3,000,000 | $10.82 | $32,465,000.00 | +10.6% | |
| Mar 14, 2017 | Herendeen Paul | EVP And CFO | Buy | 24,000 | $10.72 | $257,280.00 | +16.0% | |
| Mar 13, 2017 | Pershing Square Capital Management, L.P.74 | Director | Sell | 18,114,432 | $11.00 | $199,258,752.00 | -100% | |
| Dec 14, 2016 | Ross Thomas W. Sr. | Director | Buy | 5,000 | $14.73 | $73,650.00 | +22.9% | |
| Dec 12, 2016 | Pershing Square Capital Management, L.P.74 | Director | Sell | 3,476,690 | $14.85 | $51,628,846.50 | -16.1% | |
| Aug 11, 2016 | Karabelas Argeris N73 | Director | Buy | 4,000 | $24.65 | $98,600.00 | +23.9% | |
| Jun 13, 2016 | Ross Thomas W. Sr. | Director | Buy | 4,000 | $24.40 | $97,600.00 | +22.4% | |
| Jun 10, 2016 | Papa Joseph C | Chairman &CEO | Buy | 202,000 | $24.48 | $4,944,960.00 | +9.0% |